RxDoctor Payments Data

Aaron Goldberg, MD

Gynecology · Richmond, VANPI 1649475260

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (58.7%), food and beverage and education — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by AbbVie at 58.7% of the total. Reporting peaked in 2020 at $425 and has fallen 67.4% since, to $138 in 2024.

$724in general payments, 2019–2025

Across 8 payments — averaging $90.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$425
  • Astellas Pharma US Inc$201
  • Johnson & Johnson$33
  • Myovant Sciences Inc.$32
  • Coopersurgical, Inc.$21
  • Hologic Sales And Service, LLC$12
$29,150in research payments, 2019–2025

Across 2 payments — averaging $14,575 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$29K

What the payments were for

  • Consulting fees$42559%
  • Food & beverage$28239%
  • Education$162%

General payments by program year

20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$724 in reported general payments places this provider in the 60th percentile of 71 gynecology providers in Virginia.

See all gynecology providers in Virginia

Medicare billing

Part B allowed, 2024
$11,724
Medicare patients
61
Services billed
81

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gynecology in Richmond

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →